Implementing Genetic Findings to Drug Development Through Microphysiological Systems & In Vivo Methods
Time: 11:15 am
day: Conference Day One
Details:
- Assessing how genetic variants impact the MoA of obesity
- Investigating the use of microphysiological systems for novel obesity therapeutic development
- Manipulating multicellular organoids to replicate human level models for obesity, liver disease and NASH
